Clinical Trial Update: Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of carboplatin and paclitaxel in elderly women with newly diagnosed ovarian, primary peritoneal, or related cancers; study terminated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Mixed Tumor Mesodermal
• Ovarian Cancer
• Peritoneal Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Ovarian Cancer, Primary Peritoneal Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2015-06-17